RARA and acute promyelocytic leukemia: APL is a very homogenous disease characterized by the PML-RARA translocation with exceptionally good prognosis when treated with all-trans retinoic acid (ATRA) based therapy in combination with chemotherapy or arsenic trioxide (ATO) [7,8].